Leading Oncology Biomarker Companies Transforming the Healthcare Industry
Highlighting leading oncology biomarker companies, this edition explores innovations in diagnostics, personalized medicine, and early detection, showcasing how advanced research and technology are improving cancer care and patient outcomes worldwide.
Cover Story
Cerba Research: Enabling the Next Generation of Clinical Innovation
The clinical research industry is entering a phase where laboratory partners are no longer measured by testing volume alone, but by their ability to turn complex biological data into decisions that move trials forward faster. As precision medicine expands, the
Cerba Research: Enabling the Next Generation of Clinical Innovation
The clinical research industry is entering a phase where laboratory partners are no longer measured by testing volume alone, but by their ability to turn complex biological data into decisions that move trials forward faster. As precision medicine expands, the
Issue Profiles
Next Generation Medicine
For most of medical history, treatment decisions were made based on what worked for most people with a given condition. The same medication at the same dose was given to patients...
Smarter Diagnostic Solutions
Every effective treatment plan starts with an accurate understanding of what is actually wrong. Before a clinician can decide how to help a patient, they need to know what...